1. Home
  2. NEO vs EVER Comparison

NEO vs EVER Comparison

Compare NEO & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • EVER
  • Stock Information
  • Founded
  • NEO 2001
  • EVER 2008
  • Country
  • NEO United States
  • EVER United States
  • Employees
  • NEO N/A
  • EVER N/A
  • Industry
  • NEO Precision Instruments
  • EVER Computer Software: Programming Data Processing
  • Sector
  • NEO Health Care
  • EVER Technology
  • Exchange
  • NEO Nasdaq
  • EVER Nasdaq
  • Market Cap
  • NEO 965.2M
  • EVER 960.3M
  • IPO Year
  • NEO 1999
  • EVER 2018
  • Fundamental
  • Price
  • NEO $7.17
  • EVER $23.81
  • Analyst Decision
  • NEO Buy
  • EVER Strong Buy
  • Analyst Count
  • NEO 9
  • EVER 6
  • Target Price
  • NEO $13.31
  • EVER $32.50
  • AVG Volume (30 Days)
  • NEO 1.6M
  • EVER 559.8K
  • Earning Date
  • NEO 04-29-2025
  • EVER 05-05-2025
  • Dividend Yield
  • NEO N/A
  • EVER N/A
  • EPS Growth
  • NEO N/A
  • EVER N/A
  • EPS
  • NEO N/A
  • EVER 1.03
  • Revenue
  • NEO $672,361,000.00
  • EVER $575,757,000.00
  • Revenue This Year
  • NEO $13.95
  • EVER $31.67
  • Revenue Next Year
  • NEO $11.16
  • EVER $11.31
  • P/E Ratio
  • NEO N/A
  • EVER $23.05
  • Revenue Growth
  • NEO 10.10
  • EVER 113.43
  • 52 Week Low
  • NEO $6.08
  • EVER $16.63
  • 52 Week High
  • NEO $19.12
  • EVER $30.03
  • Technical
  • Relative Strength Index (RSI)
  • NEO 37.02
  • EVER 47.03
  • Support Level
  • NEO $7.28
  • EVER $22.76
  • Resistance Level
  • NEO $7.63
  • EVER $23.62
  • Average True Range (ATR)
  • NEO 0.36
  • EVER 0.74
  • MACD
  • NEO -0.00
  • EVER -0.07
  • Stochastic Oscillator
  • NEO 9.26
  • EVER 35.68

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

Share on Social Networks: